Liver cancer: Lipid synthesis promotes tumor formation
New publication in Cancer Cell: Protein mTOR stimulates the production of lipids in liver tumors.
Tubules to stop cell growth
Nature paper by the Loewith group on new TORC1 structure in cells. Congratulations!
New health research shines a light on ‘circadian clock’ at work in our muscles
Researchers funded by the SNSF have discovered a biological clock at work in our muscle cells. It could be a factor in regulating our metabolism and play a role in diabetes.
Lasker Award 2017 for Michael N. Hall
The work of Hall has led to a fundamental change in how one thinks of cell growth and has provided critical information for the development of anti-cancer drugs. The Lasker Award is known as the highest award in medical sciences in the US.
Antibody-based biosensors offers unlimited point-of-care drug monitoring
A breakthrough for the general pipeline of biosensors : a new antibody-linked biosensor can identify a synthetic drug in a patient’s blood sample.
Selective Targeting of SH2 Domains of SFKs with Monobodies
Development of high-performance synthetic binding proteins, termed monobodies, that prove to be effectively and specifically targeted to the SH2 domains of SFKs.
Anti-cancer drug gets a boost when combined with antirheumatic
Combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery, co-funded by the NCCR Chemical Biology, opens a new path for drug-drug synergy.
Structure and conserved function of iso-branched sphingoid bases from the nematode C. elegans
The collaborative efforts of two NCCR groups, the Riezman lab and the Zumbühl group, were recently reported in Chemical Science.
Best Master’s Thesis Award 2017 to Nour Mozaffari
Nour Lydia Mozaffari has been granted the Best Master Thesis Award 2017 for her work entitled: “Superresolution imaging of the TORC1 focus in Saccharomyces cerevisiae”.
EPFL Spin-off Cellestia Biotech raises CHF 8 million in seed financing
The company can now carry out clinical trials on its new cancer treatment which has shown excellent efficacy in laboratory tests, and the company has filed several patents.
